A mosaic embryo contains a mix of cells with different chromosomal numbers, some normal and some abnormal, arising after fertilization. In in vitro fertilization (IVF), this term appears in preimplantation genetic testing for aneuploidy (PGT-A) reports and influences how clinicians discuss transfer, freezing, and future pregnancy options. Understanding mosaicism helps patients interpret risk, set expectations, and choose next steps without overestimating prognosis or underestifying viable potential.
What Is Mosaicism in Embryos
Mosaicism in embryos means that not all cells in the embryo share the exact same chromosome makeup. It arises when an error in chromosome segregation occurs after fertilization, leading to a mixture of cell lines. Some cells are euploid (normal chromosome number), while others are aneuploid (abnormal number). This is distinct from full aneuploidy, where every cell carries the same abnormality. Mosaic embryos are one category in preimplantation genetic testing for aneuploidy (PGT-A) reports, alongside euploid and ananeuploid results.
How Mosaicism Differs From Normal and Aneuploid Embryos
In PGT-A, each biopsy is analyzed to estimate the proportion of cells with abnormal chromosomes. Euploid embryos have all cells with a normal count; aneuploid embryos have widespread abnormalities; mosaic embryos show a mix. The degree of mosaicism, often reported as low, moderate, or high, reflects the proportion of abnormal cells inferred from the tested sample. This distinction shapes how clinicians interpret implantation potential and pregnancy outcomes.
How Mosaic Embryos Are Graded in PGT-A
Clinical laboratories typically assign a grade or category based on the estimated level of mosaicism and the chromosomes involved. Grading systems vary, but they commonly describe the findings in clear terms to guide decisions. Key elements include whether the mosaicism affects autosomes or sex chromosomes and whether whole chromosome or segmental abnormalities are present.
Common Grading Terms and What They Suggest
Clinicians use terms such as low-level mosaic, moderate mosaic, and high-level mosaic to convey risk and likelihood of viable pregnancy. Some reports also note specific chromosome involvement, such as mosaicism primarily affecting chromosome 16 or the sex chromosomes. These details help tailor counseling, because risk and prognosis can differ by chromosome and pattern. The table below summarizes common grading elements and their clinical implications.
| Grading Element | Verified Detail | Source Type |
|---|---|---|
| Low-level mosaic | Small proportion of abnormal cells; higher chance of ongoing pregnancy | PGT-A laboratory and clinical studies |
| Moderate mosaic | Intermediate proportion of abnormal cells; variable potential for viable pregnancy | PGT-A laboratory and clinical studies |
| High-level mosaic | Large proportion of abnormal cells; lower implantation and pregnancy potential | PGT-A laboratory and clinical studies |
| Chromosome-specific involvement | Risk and prognosis can differ by affected chromosome | PGT-A reporting guidelines |
Clinical Implications of Mosaicism for IVF
When a biopsy shows mosaicism, clinics typically discuss the result in the context of the patient’s age, diagnosis, embryo quality, and prior history. Some mosaic embryos can progress to live birth, particularly low-level mosaics involving chromosomes other than 16 or 18. However, they also carry a higher risk of miscarriage or pregnancy complications compared with euploid embryos. Transfer decisions depend on balancing potential benefit against risks, and many teams recommend closer obstetric monitoring if a mosaic embryo is transferred.
Pregnancy Outcomes and Recurrence Risk
Outcomes with mosaic embryos vary, with some studies reporting lower but still meaningful implantation and ongoing pregnancy rates compared with euploid embryos. The risk of miscarriage is generally elevated relative to euploid transfers. Mosaicism detected in a pregnancy often, but not always, decreases over time as abnormal cells are diluted or selected against. Recurrence risk in subsequent cycles can be higher than in couples without mosaicism, though data are heterogeneous and should be personalized with a clinician.
Options and Counseling After a Mosaic Result
Patients with mosaic embryos have several options, including transfer of mosaic embryos, selective transfer of euploid embryos when available, or freezing and reanalysis in a subsequent cycle. Some opt to avoid transfer of high-level mosaics and instead consider donor gametes or alternative family-building paths. Detailed genetic counseling is recommended to explain limitations, interpret reports, and align decisions with personal values. Counseling should cover recurrence risk, monitoring plans, and realistic success rates.
What Patients Should Ask Their Care Team
- What is the exact chromosome pattern and level of mosaicism reported?
- How does this affect the estimated chance of live birth and miscarriage?
- Would you recommend transfer, refreezing, or additional testing?
- What prenatal testing and monitoring are suggested if we proceed?
- How might this result influence plans for future cycles?
Limitations of Current Evidence
Data on mosaic embryos come from PGT-A series, cohort studies, and retrospective analyses, which can differ in laboratory methods and outcome definitions. Mosaicism testing is inherently limited because only a small number of cells are biopsied and analyzed, so the true proportion in the whole embryo is inferred. As a result, classifications and prognostic estimates should be considered alongside clinical context rather than used in isolation. Guidelines evolve as more longitudinal data on offspring health become available.
Key Takeaways on Mosaic Embryos
- Mosaic embryos contain a mix of cells with normal and abnormal chromosomes and are common in PGT-A.
- Grading aims to convey likelihood of viable pregnancy, with lower-level mosaics generally associated with better outcomes.
- Outcomes are variable; mosaic transfers can succeed but carry higher miscarriage risk than euploid transfers.
- Personalized counseling, detailed reporting, and multidisciplinary care help patients make informed choices.
- Ongoing research continues to refine classification, prognosis, and long-term child health follow-up.
Because practices and evidence continue to evolve, patients should review mosaic results with their fertility or genetic counselor to understand how they apply to their individual circumstances, treatment history, and goals.